Veracyte, Inc. (VCYT)
47.29
-1.44
(-2.96%)
USD |
NASDAQ |
Jun 08, 16:00
47.29
0.00 (0.00%)
After-Hours: 20:00
Veracyte Enterprise Value : 3.489B for June 5, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 20.10M |
| Quantum Cyber NV | 23.25M |
| bioAffinity Technologies, Inc. | 6.067M |
| Ionis Pharmaceuticals, Inc. | 12.99B |
| Recursion Pharmaceuticals, Inc. | 1.171B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 28.71M |
| Revenue (Quarterly) | 139.07M |
| Total Expenses (Quarterly) | 110.36M |
| EPS Diluted (Quarterly) | 0.353 |
| Gross Profit Margin (Quarterly) | 72.32% |
| Profit Margin (Quarterly) | 20.64% |
| Earnings Yield | 2.30% |
| Operating Earnings Yield | 2.30% |
| Normalized Earnings Yield | 2.385 |